Research Calls I
- Upgrades:
- American Axle (AXL) upgraded to Overweight from Underweight at Morgan Stanley; tgt raised to $16
- American Electric (AEP) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $101
- Autohome (ATHM) upgraded to Buy from Hold at The Benchmark Company; tgt $44
- Block (SQ) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt $159
- Bloom Energy (BE) upgraded to Positive from Neutral at Susquehanna; tgt raised to $33
- Cable ONE (CABO) upgraded to Overweight from Equal Weight at Wells Fargo; tgt $2100
- Dollar Tree (DLTR) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $170
- ExlService (EXLS) upgraded to Outperform from Market Perform at Cowen; tgt raised to $145
- MacroGenics (MGNX) upgraded to Buy from Neutral at Citigroup; tgt lowered to $21
- Ovintiv (OVV) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $50
- Paylocity (PCTY) upgraded to Buy from Hold at Jefferies; tgt $255
- PulteGroup (PHM) upgraded to Buy from Underperform at BofA Securities
- TechnipFMC (FTI) upgraded to Buy from Hold at Kepler
- Tenaris (TS) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $32
- Texas Roadhouse (TXRH) upgraded to Buy from Hold at Gordon Haskett; tgt $110
- Toll Brothers (TOL) upgraded to Buy from Underperform at BofA Securities; tgt raised to $63
- Downgrades:
- AbbVie (ABBV) downgraded to Neutral from Buy at UBS; tgt raised to $147
- Bally's Corporation (BALY) downgraded to Hold from Buy at Jefferies; tgt lowered to $38
- Deciphera Pharmaceuticals (DCPH) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $6
- EPAM Systems (EPAM) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $410
- Foot Locker (FL) downgraded to Sell from Buy at Citigroup; tgt lowered to $25
- Foot Locker (FL) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $23
- Gilead Sciences (GILD) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $65
- Goldman Sachs BDC (GSBD) downgraded to Equal Weight from Overweight at Wells Fargo
- Jack In The Box (JACK) downgraded to Hold from Buy at Gordon Haskett; tgt $96
- Lear (LEA) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $175
- Prelude Therapeutics (PRLD) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $12
- Qurate Retail Group (QRTEA) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $6.30
- Universal Health (UHS) downgraded to Neutral from Buy at Seaport Research Partners
- Others:
- Ambrx Biopharma (AMAM) initiated with a Neutral at Goldman; tgt $6
- First Bancorp (FBNC) resumed with an Outperform at Raymond James; tgt $49
- GoPro (GPRO) initiated with a Buy at Jefferies; tgt $12
- Jasper Therapeutics (JSPR) initiated with an Overweight at Cantor Fitzgerald; tgt $10
- Kinetik (KNTK) resumed with an Outperform at Credit Suisse; tgt $72
- Olema Pharmaceuticals (OLMA) initiated with a Neutral at H.C. Wainwright
- Travere Therapeutics (TVTX) initiated with a Buy at H.C. Wainwright; tgt $45
- Virgin Orbit Holdings (VORB) initiated with a Buy at Canaccord Genuity; tgt $20